North America lithium-ion battery binder market was valued at $567.6 million in 2025 and is projected to reach $2,589.1 million by 2035, growing at a CAGR of 16.4% during the forecast period 2026–2035, according to a new report by Orion Market Research. The North American lithium-ion battery binder market is driven by growing EV and energy storage demand, increasing adoption of high-performance binders like PVDF and water-based systems, and local capacity expansions by suppliers such as BASF, Arkema, and Trinseo. Among these, the scale-up of gigafactories across North America is creating steady, high-volume demand for binders in the market.

Asia-Pacific additive manufacturing & material market was valued at $9.0 billion in 2024 and is projected to reach $82.2 billion by 2035, growing at a CAGR of 22.3% during the forecast period (2025–2035). The Asia-Pacific additive manufacturing & materials market is witnessing robust growth, supported by accelerating industrialization, strong government support for advanced manufacturing, and increasing adoption of Industry 4.0 practices across key economies such as China, Japan, South Korea, and India. Manufacturing sectors, including automotive, aerospace, electronics, healthcare, and industrial machinery, are increasingly integrating additive manufacturing to enable rapid prototyping, lightweight component production, design optimization, and cost-efficient low-volume manufacturing.

European narrow band IoT market was valued at $922.5 million in 2025 and is projected to reach $6,706.8 million by 2035, growing at a CAGR of 22.0% during the forecast period 2026–2035, according to a new report by Orion Market Research. The European NB-IoT market is driven by rapid adoption in utility metering, smart cities, and industrial IoT. Its advantages include low power consumption, wide coverage, and the ability to connect massive numbers of devices. Regulatory mandates, particularly the MID update and other mandate standards, are a major growth driver. These rules require two-way communication, bidirectional measurement, and reliable deep-indoor connectivity, prompting utilities to replace legacy meters with NB-IoT-enabled devices. This is creating sustained, high-volume demand for NB-IoT modules, connectivity services, and related infrastructure across Europe.

Asia-Pacific agriculture microbiome market was valued at $2,838.7 million in 2025 and is projected to reach $12.921.0 million by 2035, growing at a CAGR of 16.5% during the forecast period 2026–2035, according to a new report by the Orion Market Research. The Asia-Pacific Agriculture Microbiome Market is driven by the growing use of microbial solutions to improve soil health and crop productivity, along with rising awareness of sustainable farming and supportive government policies for biofertilizers. However, climate change is the strongest growth driver, as increasing heatwaves, droughts, and soil salinity are pushing farmers to adopt microbiome-based products to protect yields and build climate-resilient agriculture.

US interleukin inhibitors market was valued at $14,680.6 million in 2025 and is projected to reach $42.141.1 million by 2035, growing at a CAGR 11.2% during the forecast period (2026–2035). Interleukin inhibitors are biologic therapies designed to target specific interleukin pathways involved in inflammatory and autoimmune disorders, and are widely used in the treatment of conditions such as psoriasis, psoriatic arthritis, atopic dermatitis, rheumatoid arthritis, asthma, and inflammatory bowel disease. Market growth is driven by the rising prevalence of chronic immune mediated diseases, increasing adoption of targeted biologic therapies, strong clinical efficacy profiles, and expanding indications for next-generation IL-17, IL-23, IL-4/13, and IL-5 inhibitors.

US healthcare contract development and manufacturing organization (CDMO) market was valued at $171.3 billion in 2025 and is growing at a CAGR of 6.4% during the forecast period 2026-2035. The US healthcare contract development and manufacturing organization (CDMO) market is experiencing steady growth as pharmaceutical and biotechnology companies increasingly outsource drug development and manufacturing to specialized partners. Rising demand for complex therapies, including biologics, sterile injectables, and high-potency small molecules, is driving the need for advanced technical capabilities and flexible manufacturing solutions. CDMOs are focusing on expanding their capacity, adopting automation, and implementing digital quality systems to improve efficiency and compliance. Long-term collaborations are becoming more common, as companies seek reliable partners to navigate regulatory complexities and accelerate time-to-market. Additionally, there is growing emphasis on localized manufacturing within the US to strengthen supply chain resilience and meet domestic demand. Overall, the market is evolving toward integrated, end-to-end service offerings that combine development, analytical testing, and commercial-scale production.

UK interleukin inhibitors market was valued at $2,426.4 million in 2025 and is projected to reach $6,006.7 million by 2035, growing at a CAGR of 9.5% during the forecast period (2026–2035). Interleukin inhibitors are targeted biologic therapies designed to modulate specific inflammatory pathways and are widely used in the treatment of autoimmune and chronic inflammatory diseases such as psoriasis, rheumatoid arthritis, atopic dermatitis, asthma, and inflammatory bowel disease. Market growth is driven by the rising prevalence of immune-mediated disorders, increasing adoption of biologics over conventional systemic therapies, and expanding reimbursement support through the National Health Service (NHS).

North America interleukin inhibitors market was valued at $15,869.7 million in 2025 and is projected to reach $45,240.0 million by 2035, growing at a CAGR of 11.1% during the forecast period (2026–2035). Interleukin inhibitors comprise biologic and targeted immunomodulatory therapies designed to block specific interleukin pathways such as IL-17, IL-23, IL-6, IL-4/13, and IL-5, and are widely used in the treatment of autoimmune and inflammatory disorders including psoriasis, psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease, asthma, and atopic dermatitis. Market growth is driven by the rising prevalence of chronic immune-mediated diseases, strong clinical efficacy of next-generation biologics, expanding indications, and favorable reimbursement frameworks across the United States and Canada.

Solar water pump market was valued at $2,200.2 million in 2025 and is projected to reach $4,794.0 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). Solar water pumps are used to supply water for agricultural irrigation, livestock, residential, and industrial applications, offering a sustainable and energy-efficient alternative to conventional diesel or electric pumps. Market growth is being driven by increasing adoption of renewable energy solutions, government incentives for solar irrigation and water management, rising energy costs, and the growing need for sustainable water supply solutions in regions facing water scarcity and unreliable electricity access.

Europe personal care appliances market was valued at $5.8 billion in 2024 and is projected to reach $9.7 billion by 2035, growing at a CAGR of 4.8% during the forecast period (2025-2035). The European personal care appliances market is witnessing consistent expansion, supported by evolving consumer lifestyles, rising grooming awareness, and a strong emphasis on personal hygiene and appearance. Increasing urbanization, higher disposable incomes, and the growing influence of wellness-oriented living are encouraging consumers to adopt advanced grooming and beauty appliances for both home and professional use.